Concepedia

Synthesis of [1,2,4]triazolo[1,5-a]pyrazines as adenosine A2A receptor antagonists

James J. Dowling, Jeffrey T. Vessels, Serajul Haque, He Xi Chang, Kurt van Vloten, G. Kumaravel, Thomas M. Engber, Xiaowei Jin, Deepali Phadke, Joy Wang,

Bioorganic & Medicinal Chemistry Letters · 2005 · 26 citations · 23 references

DOIFull text

Open access

Concepts

References

23

Receptors for Purines and Pyrimidines

Geoffrey Burnstock, Alexei Verkhratsky · 2012 · 4K citations

, , +10

Neuroprotection by Caffeine and A<sub>2A</sub>Adenosine Receptor Inactivation in a Model of Parkinson's Disease

Jiang‐Fan Chen, Kui Xu, Jacobus P. Petzer et al. · Journal of Neuroscience · 2001 · 447 citations · Full text

, , +17

The in vitro pharmacology of ZM 241385, a potent, non‐xanthine, A<sub>2a</sub>selective adenosine receptor antagonist

Simon M. Poucher, J R Keddie, Parminder Singh et al. · British Journal of Pharmacology · 1995 · 364 citations · Full text

, , +8

Adenosine A<sub>2A</sub> Antagonist: A novel antiparkinsonian agent that does not provoke dyskinesia in Parkinsonian monkeys

Tomoyuki Kanda, Michael Jackson, Lance A. Smith et al. · Annals of Neurology · 1998 · 356 citations

, , +16

Adenosine A <sub>2A</sub> receptor antagonist treatment of Parkinson’s disease

William Bara‐Jimenez, Ayesha Sherzai, Tzvetelina Dimitrova et al. · Neurology · 2003 · 327 citations

, , +17